USP17L14P

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, USP17L14P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of USP17L14P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where USP17L14P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types USP17L14P is over-expressed in tumor.

BRCA are the cancer types where USP17L14P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in USP17L14P RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
BRCAAllII,III,IV+0.003.0294view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

USP17L14P–BRCA

Tumor-vs-normal expression box plot for USP17L14P RNA in BRCA.

Open the BRCA breakdown →

Exploration